Rennova Health, Inc.
RNVA · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 43.3% | 304.4% | -55.2% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 59.5% | 48.1% | -64.2% | -63.7% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 7.8% | -2.4% | -39.2% | -116.8% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -41.4% | -25.3% | 173.9% | -254.7% |
| EPS Diluted | -0 | -0.033 | -913.37 | -93,864,830.67 |
| % Growth | 99.4% | 100% | 100% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |